Cargando…
Expression of some selected cytokeratins and Ki67 protein in prostatic tumor: can these be used as tumor markers
INTRODUCTION: Diagnosis of prostatic diseases with Immunohistochemistry still faces challenges because of the peculiar histology of the prostate and difference(s) in reactivity of Monoclonal antibodies (MoAb) to benign and malignant changes. METHODS: Thirty (30) archived paraffin embedded tissue sam...
Autores principales: | Adisa, James Olayiwola, Egbujo, Ejike Chukwudi, Ibrahim, Babangida, Musa, Bukar, Madukwe, Jonathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The African Field Epidemiology Network
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449993/ https://www.ncbi.nlm.nih.gov/pubmed/26090004 http://dx.doi.org/10.11604/pamj.2015.20.46.3926 |
Ejemplares similares
-
Gene Expression of Aurora Kinases in Prostate Cancer and Nodular Hyperplasia Tissues
por: Nna, Emmanuel, et al.
Publicado: (2013) -
Quantum Dots-Based Quantitative and In Situ Multiple Imaging on Ki67 and Cytokeratin to Improve Ki67 Assessment in Breast Cancer
por: Yuan, Jing Ping, et al.
Publicado: (2015) -
Cytokeratin 13, Cytokeratin 17, and Ki-67 Expression in Human Acquired Cholesteatoma and Their Correlation With Its Destructive Capacity
por: Hamed, Mahmood A., et al.
Publicado: (2017) -
Cytokeratin 17 and Ki-67: Immunohistochemical markers for the differential diagnosis of keratoacanthoma and squamous cell carcinoma
por: Leblebici, Cem, et al.
Publicado: (2017) -
Ki-67 is a prognostic marker for hormone receptor positive tumors
por: Pérez-López, M. E., et al.
Publicado: (2016)